Celldex Therapeutics (NASDAQ: CLDX) issues Q2 2026 earnings press release
Rhea-AI Filing Summary
Celldex Therapeutics, Inc. states that on August 6, 2026 it issued a press release announcing its financial results for the second quarter of 2026. The press release is provided as Exhibit 99.1 and is treated as information that is furnished, rather than filed, under the Exchange Act, limiting its treatment under Section 18 and other liability provisions.
The company also identifies Exhibit 104 as the cover page interactive data file embedded within the Inline XBRL document. Any future use of the press release in Securities Act or Exchange Act reports will occur only if specifically incorporated by reference.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Terms
Section 18 of the Securities Exchange Act of 1934, incorporated by reference, Inline XBRL, Emerging growth company
4 terms
Section 18 of the Securities Exchange Act of 1934 regulatory
"for purposes of Section 18 of the Securities Exchange Act of 1934, as amended"
incorporated by reference regulatory
"nor shall such information be deemed incorporated by reference in any filing"
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
Emerging growth company regulatory
"Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Earnings Snapshot
second quarter of 2026
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Celldex Therapeutics (CLDX) announce on August 6, 2026?
Celldex Therapeutics announced that on August 6, 2026 it issued a press release with financial results for the second quarter of 2026. The release is included as Exhibit 99.1 and is provided as furnished information rather than as a filed document.
How did Celldex Therapeutics (CLDX) communicate its Q2 2026 financial results?
Celldex Therapeutics communicated its Q2 2026 financial results through a press release furnished as Exhibit 99.1. That exhibit forms part of a current report and is designated as furnished, which affects how it is treated under Exchange Act liability provisions.
Which reporting period do the latest Celldex Therapeutics (CLDX) results cover?
The latest results disclosed by Celldex Therapeutics cover the second quarter of 2026. This period is specified in the description of the press release, which the company identifies as announcing its financial results for that quarter.
How is the Celldex Therapeutics (CLDX) earnings press release treated under the Exchange Act?
The earnings press release is treated as furnished, not filed, under the Exchange Act. The company states it is not deemed filed for Section 18 purposes and is not incorporated by reference into Securities Act or Exchange Act filings unless specifically referenced.
What exhibits accompany Celldex Therapeutics (CLDX)’s August 6, 2026 current report?
The company lists two exhibits: Exhibit 99.1, a press release dated August 6, 2026 with second-quarter 2026 financial results, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.